Question

Difficulty: MediumPharmacologic Interventions

A 7474-year-old man presents to the clinic with a 33-day history of dysuria, increased urinary frequency, and suprapubic discomfort. His medical history is significant for a mechanical aortic valve replacement and stage 44 chronic kidney disease. Current medications include warfarin and amlodipine. He has a history of anaphylactic shock following penicillin administration in his twenties. Vital signs include a temperature of 37.1∘C37.1^\circ \text{C} (98.8∘F98.8^\circ \text{F}), blood pressure of 138/82 mmHg138/82 \text{ mmHg}, and heart rate of 76/min76/\text{min}. Laboratory evaluation reveals a serum creatinine of 2.6 mg/dL2.6 \text{ mg/dL} (baseline 2.5 mg/dL2.5 \text{ mg/dL}) and an estimated glomerular filtration rate (eGFR) of 22 mL/min/1.73 m222 \text{ mL/min/}1.73\text{ m}^2. His international normalized ratio (INR) is currently 2.52.5. Urinalysis is positive for leukocyte esterase and nitrites, with 4040 white blood cells per high-power field. Which of the following is the most appropriate empiric pharmacologic intervention for this patient's condition?

  1. A
    Trimethoprim-sulfamethoxazole
  2. B
    Nitrofurantoin
  3. C
    Amoxicillin-clavulanate
  4. FosfomycinAnswer
  5. E
    Doxycycline

Answer

Fosfomycin
Fosfomycin is an appropriate first-line oral agent for acute uncomplicated cystitis. It is uniquely suited for this medically complex patient because it does not require dose adjustments and is not contraindicated in severe chronic kidney disease (maintaining efficacy in the bladder), does not interact with warfarin metabolism, and has a distinct chemical structure unrelated to beta-lactams, making it completely safe for patients with a history of penicillin anaphylaxis.

Step-by-Step Solution

1
Diagnose the acute condition based on clinical and laboratory findings.
The patient has acute uncomplicated cystitis (dysuria, frequency, suprapubic pain, positive urinalysis).
Establishing the diagnosis determines the spectrum of necessary antimicrobial coverage (typically targeting E. coli, Proteus, or Klebsiella).
2
Evaluate patient-specific constraints regarding medication safety.
The patient has three major pharmacological constraints: eGFR of 22 mL/min/1.73 m^2, concurrent use of warfarin, and a severe IgE-mediated penicillin allergy.
Standard first-line UTI medications carry significant risks or contraindications when combined with these specific comorbidities.
3
Select the optimal pharmacologic agent that bypasses all identified constraints.
Fosfomycin is selected because it is not renally contraindicated, does not interact with CYP enzymes affecting warfarin, and is not a beta-lactam.
This single-dose therapy provides adequate local urinary concentrations to clear the infection while maintaining systemic safety.

Key Concept

Individualizing antimicrobial pharmacotherapy by navigating concurrent drug-drug interactions, severe drug allergies, and renal impairment contraindications.
Rate this question